Top Markets
#1 Audiera Audiera +38.20%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +33.00%
#3 Bitcoin Cash Bitcoin Cash +32.56%
#4 Tutorial Tutorial +30.97%
#5 Fabric Protocol Fabric Protocol +30.73%
#6 Prom Prom +28.96%
#7 GALA GALA +27.57%
#8 Ethena Staked ENA Ethena Staked ENA +26.37%
#9 Arowana Arowana +26.33%
#10 Useless Coin Useless Coin +24.76%
Coin of the day
Audiera Audiera
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Classement en actions #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Prix de l'action
$3.09
Capitalisation boursière
$58.82M
Changement (1 jour)
0.33%
Changement (1 an)
-73.01%
Pays
US
Échange Elicio Therapeutics, Inc. (ELTX)

Catégorie

Healthcare
Ratio P/B pour Elicio Therapeutics, Inc. (ELTX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Elicio Therapeutics, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Elicio Therapeutics, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH